Search


	Podcast:		OncLive® On Air
	Episode:		48: FDA Approval Insights: Umbralisib in Marginal Zone Lymphoma and Follicular Lymphoma
	Category:		Science & Medicine
	Duration:		00:09:11
	Publish Date:		2021-04-12 20:21:57
	Description:		In our exclusive interview, Fowler discussed the data that served as the basis for the accelerated approval of umbralisib in marginal zone lymphoma and follicular lymphoma, explained the implications of the regulatory decision on clinical practice, and detailed potential next steps for the PI3Kδ and CK1ε inhibitor.
	Total Play:		0